mission & valuespartner bios


About Viacure

Viacure Research Inc. (Recherche Viacure Inc.) was formed in 2003 as a result of the strategic alliance between Clinsight Research Inc. in Toronto and Dataccure Associates in Montreal. This partnership was formed to meet the evolving needs of today's pharmaceutical and biotechnology companies.

The partnership, which was designed to meet the growing needs of two growing client lists, created a uniquely structured organization; Viacure is a national multilingual clinical research organization (CRO) with an extended network of independent and regionally located certified clinical research associates (CRAs), knowledgeable in a range of therapeutic areas.

Together, Viacure's Management Team boasts over 25 years of clinical experience in the biotechnology and pharmaceutical industries. This experience enables Viacure to offer a comprehensive range of clinical trial management services, including:

Project Management
Site Qualification
Regulatory Review
Project Coordination & Tracking
Clinical Monitoring & Site Management
Quality Assurance Auditing

At every stage of the project, Viacure will remain focused on the client's clinical research objectives. By reviewing each protocol in detail, Viacure is able to identify any potential protocol challenges. Investigative sites are assessed and recruited according to their ability to provide the protocol study population and qualified staff to successfully complete the study. Regional CRAs are selected to work on a particular protocol based upon their relevant therapeutic expertise. Our customized, common-sense approach to clinical trial monitoring and site management assists our clients with the expedition of their products to market.

Through effective project management and site monitoring, Viacure is committed to the timely and cost-effective development of the drug or device under investigation. Our goal is to provide accurate, complete data that will lead to the treatment, management or cure of diseases, for a better quality of life for all patients.